Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | KCNJ1 | P48048 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.51 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.51 |
| ▸ | CDK9 | P50750 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9721024 | 0.95 | KDM4E (0.64) | KDM4EKCNJ1ALDH1A1LMNAMAPT | |
| SCHEMBL783686 | 0.95 | KDM4E (0.64) | KDM4EKCNJ1ALDH1A1LMNAMAPT | |
| SCHEMBL9720944 | 0.95 | KDM4E (0.64) | KDM4EKCNJ1ALDH1A1LMNAMAPT | |
| SCHEMBL8601352 | 0.92 | KDM4E (0.80) | KDM4EKCNJ1ALDH1A1LMNAMAPT | |
| SCHEMBL9642123 | 0.92 | MAPT (0.78) | KDM4EKCNJ1ALDH1A1LMNAMAPT | |
| SCHEMBL7033532 | 0.90 | MAPT (0.72) | KDM4EKCNJ1ALDH1A1LMNAMAPT | |
| SCHEMBL7608611 | 0.89 | KDM4E (0.85) | KDM4EKCNJ1ALDH1A1LMNAMAPT | |
| SCHEMBL6753972 | 0.86 | GAA (0.64) | KDM4EKCNJ1ALDH1A1LMNAMAPT | |
| SCHEMBL1250581 | 0.85 | KDM4E (0.82) | KDM4EKCNJ1ALDH1A1LMNAMAPT | |
| SCHEMBL7099247 | 0.84 | KDM4E (0.53) | KDM4EKCNJ1ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5173130-A | Immersing copper or alloy to be soldered in an aqueous solution containing a 2-alkylbenzimidazole and an organic acid to form a corrosion and heat resistant protective coating | SHIKOKU CHEMICALS CORPORATION (JP) | 1992-12-22 | — | — | US | claimed |
| CN-1095623-C | Organic-metallic composite coating for copper surface protection | IBM (US) | 2002-12-04 | — | — | CN | disclosed |
| US-20020067486-A1 | Solderability assessment | AMERICAN COMPETITIVENESS INSTITUTE | 2002-06-06 | — | — | US | disclosed |
| US-5960251-A | Organic-metallic composite coating for copper surface protection | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1999-09-28 | — | — | US | disclosed |
| US-5864043-A | CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST | KARL THOMAE GMBH (DE) | 1999-01-26 | — | — | US | disclosed |
| CN-1188589-A | Organic-metal composite coating for copper surface protection | IBM (US) | 1998-07-22 | — | — | CN | disclosed |
| WO-1997039610-A1 | ORGANIC-METALLIC COMPOSITE COATING FOR COPPER SURFACE PROTECTION | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1997-10-23 | — | — | WO | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |
| US-5519138-A | ANGIOTENSIN ANTAGONIST | DR. KARL THOMAE GMBH (DE) | 1996-05-21 | — | — | US | disclosed |
| EP-0392317-B1 | Benzimidazoles, drugs containing these compounds and process for their preparation | THOMAE GMBH DR K (DE) | 1996-01-03 | — | — | EP | disclosed |
| CN-1029961-C | Benzimidazole derivatives, their prodn. and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1995-10-11 | — | — | CN | disclosed |
| EP-0425921-B1 | Benzimidazole derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1995-08-09 | — | — | EP | disclosed |
| US-5250554-A | Cardiovascular disorders | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-10-05 | — | — | US | disclosed |
| EP-0529253-A1 | Phenylalkylderivatives, compounds containing them and process for their fabrication | Dr. Karl Thomae GmbH (DE) | 1993-03-03 | — | — | EP | disclosed |
| US-5173130-A | Immersing copper or alloy to be soldered in an aqueous solution containing a 2-alkylbenzimidazole and an organic acid to form a corrosion and heat resistant protective coating | SHIKOKU CHEMICALS CORPORATION (JP) | 1992-12-22 | — | — | US | disclosed |
| US-5128356-A | Angiotensin antagonist; cardiovascular disorders | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-07-07 | — | — | US | disclosed |
| EP-0428383-A1 | Process for surface treatment of copper and copper alloy | SHIKOKU CHEMICALS CORPORATION (JP) | 1991-05-22 | — | — | EP | disclosed |
| CN-1051355-A | Benzimidizole derivatives, its production method and application thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1991-05-15 | — | — | CN | disclosed |
| EP-0425921-A1 | Benzimidazole derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-05-08 | — | — | EP | disclosed |
| EP-0392317-A2 | Benzimidazoles, drugs containing these compounds and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1990-10-17 | — | — | EP | disclosed |